- Home
- EPAC vs NVCR Comparison
EPAC vs NVCR Comparison
Compare EPAC & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EPAC
- NVCR
- Stock Information
- Founded
- EPAC 1910
- NVCR 2000
- Country
- EPAC United States
- NVCR Switzerland
- Employees
- EPAC N/A
- NVCR N/A
- Industry
- EPAC Industrial Machinery/Components
- NVCR Medical/Dental Instruments
- Sector
- EPAC Technology
- NVCR Health Care
- Exchange
- EPAC Nasdaq
- NVCR Nasdaq
- Market Cap
- EPAC 2.3B
- NVCR 1.9B
- IPO Year
- EPAC N/A
- NVCR 2015
- Fundamental
- Price
- EPAC $37.37
- NVCR $17.55
- Analyst Decision
- EPAC Buy
- NVCR Buy
- Analyst Count
- EPAC 1
- NVCR 7
- Target Price
- EPAC $53.00
- NVCR $32.43
- AVG Volume (30 Days)
- EPAC 527.7K
- NVCR 1.3M
- Earning Date
- EPAC 06-26-2025
- NVCR 07-24-2025
- Dividend Yield
- EPAC 0.11%
- NVCR N/A
- EPS Growth
- EPAC 7.49
- NVCR N/A
- EPS
- EPAC 1.63
- NVCR N/A
- Revenue
- EPAC $608,099,000.00
- NVCR $621,711,000.00
- Revenue This Year
- EPAC $6.24
- NVCR $5.56
- Revenue Next Year
- EPAC $5.86
- NVCR $9.19
- P/E Ratio
- EPAC $23.00
- NVCR N/A
- Revenue Growth
- EPAC 2.82
- NVCR 18.27
- 52 Week Low
- EPAC $36.52
- NVCR $14.17
- 52 Week High
- EPAC $51.91
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- EPAC 28.42
- NVCR 48.98
- Support Level
- EPAC $37.33
- NVCR $16.81
- Resistance Level
- EPAC $38.54
- NVCR $18.59
- Average True Range (ATR)
- EPAC 1.30
- NVCR 0.70
- MACD
- EPAC -0.34
- NVCR 0.04
- Stochastic Oscillator
- EPAC 9.52
- NVCR 44.93
About EPAC Enerpac Tool Group Corp.
Enerpac Tool Group Corp provides high-precision tools, controlled-force products, and solutions for precise heavy lifting. The company has one reportable segment, the Industrial Tools & Services (IT&S) Segment. The IT&S segment is engaged in the design, manufacture, and distribution of branded hydraulic and mechanical tools and in providing services and tool rental to the refinery/petrochemical; general industrial; industrial maintenance, repair, and operations (MRO); machining & manufacturing; power generation; infrastructure; mining; and other markets. Geographically, the company has operations in Algeria, Australia, Brazil, France, Germany, Kazakhstan, India, Italy, Japan, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, and the United Arab Emirates.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.